<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201018049067N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-11-24</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of teaching neuro linguistic programming strategies on the level of social anxiety disorder</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effectiveness of training neuro linguistic programming strategies on the rate of social anxiety disorder and quality of life in patients with acquired immunodeficiency</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51795</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: In this study, a total of 30 people, 15 people in the intervention group and 15 people in the control group, will be included, according to the sample size intended to prevent imbalance in the number of people participating in the study in a randomized method. Simple simulation happens and researchers intend to use the Block Randomazition method. The use of this method causes a balance between the two groups, which in the sample size is less than 100 recommendations for randomization with this method. Therefore, in this study, using a table of random numbers, blocks of six or 6 people are formed and these blocks are assigned to two groups of intervention and control.</study_design>
      <phase>3</phase>
      <hc_freetext>social anxiety  disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: A group of 15 people with acquired immunodeficiency disease. The research and intervention process is as follows: First, the pre-test stage by distributing a questionnaire with the fields of social anxiety, death anxiety, quality of life, resilience, hardiness and After that, he enters the interview stage individually and after observing and taking the patient's history by the researcher, he examines the visual and perceptual system (visual, auditory, tactile) of the patient by his 5 senses and then 3 simultaneous techniques that include: 1. Empathy 2. Establish effective communication 3. Leadership in the treatment and intervention situation should be implemented. He then performs an ecological test to see if the problem is resolved or remains, and immediately performs the future pace technique so that the patient can visualize himself in the future and observe his behavior and position in the future. It then performs a basic technique called the root technique, asking: Step (1) Ask the patient what the problem is now. And here the patient looks at the problem from the outside world and expresses his observations. Step (2) If the problem persists, the patient looks at the problem again from the outside world and explains the new observation. Step (3) If the problem was solved, we came to a conclusion, but if it remained, Step (4) again We repeat the steps until the result is obtained, and after obtaining the result, the researcher again uses the technique of taking it to the future and the ecological test to observe and record the effect of implementing the technique and achieving a change in the patient's mood and solving the patient's problem. Intervention 2: Control group: For this group, only the questionnaire form is distributed with the fields of social anxiety, death anxiety, quality of life, resilience, and hardiness and After 3 months from the pre-test stage, it enters the post-test stage and the questionnaires are distributed again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information at this time</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hosein Alizadeh Barough</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Valiasr St .Islamic Azad University, Khalkhal Branch.Psychology College</address>
        <city>Khalkhal</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5681731367</zip>
        <telephone>+98 45 3245 1220</telephone>
        <email>aarmani823@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>SeyedAhmad SeyedAlinaghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>End of Keshavarz Boulevard, Imam Khomeini Hospital, behind the Infectious Diseases Department, Iran AIDS Research Center.Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733141</zip>
        <telephone>+98 21 6658 1583</telephone>
        <email>s.a.alinaghi@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Acquired immunodeficiency virus
Having social anxiety disorder</inclusion_criteria>
      <agemin>10 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with acquired immunodeficiency disease for less than (3) three years.
Affected individuals whose daily functioning and hope for the future and self-efficacy are not impaired.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F40.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Social phobias</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: A group of 15 people with acquired immunodeficiency disease. The research and intervention process is as follows: First, the pre-test stage by distributing a questionnaire with the fields of social anxiety, death anxiety, quality of life, resilience, hardiness and After that, he enters the interview stage individually and after observing and taking the patient's history by the researcher, he examines the visual and perceptual system (visual, auditory, tactile) of the patient by his 5 senses and then 3 simultaneous techniques that include: 1. Empathy 2. Establish effective communication 3. Leadership in the treatment and intervention situation should be implemented. He then performs an ecological test to see if the problem is resolved or remains, and immediately performs the future pace technique so that the patient can visualize himself in the future and observe his behavior and position in the future. It then performs a basic technique called the root technique, asking: Step (1) Ask the patient what the problem is now. And here the patient looks at the problem from the outside world and expresses his observations. Step (2) If the problem persists, the patient looks at the problem again from the outside world and explains the new observation. Step (3) If the problem was solved, we came to a conclusion, but if it remained, Step (4) again We repeat the steps until the result is obtained, and after obtaining the result, the researcher again uses the technique of taking it to the future and the ecological test to observe and record the effect of implementing the technique and achieving a change in the patient's mood and solving the patient's problem.</i_keyword>
      <i_keyword>Control group: For this group, only the questionnaire form is distributed with the fields of social anxiety, death anxiety, quality of life, resilience, and hardiness and After 3 months from the pre-test stage, it enters the post-test stage and the questionnaires are distributed again.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Social Anxiety Score. Timepoint: At the beginning of the study (before the intervention) and 3 months after the intervention. Method of measurement: Quality of Life Questionnaire, Social Anxiety, Death Anxiety, Resilience and Hardiness Scale.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: At the beginning of the study (before the intervention) and 3 months after the intervention. Method of measurement: Connor Social Panic Questionnaire (SPIN) and Quality of Life Questionnaire (SF-12) Short Form, Templer Death Anxiety Scale Questionnaire, Connor and Davidson Resilience Scale Questionnaire CD-RISC and Ahvaz Stubbornness Questionnaire 27.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Int. Academy of NLP &amp; Coching prof.Omraie</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
      <source_name>Int. Academy of NLP &amp; Coching prof.Omraie</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-11</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, ARDABIL</contact_name>
        <contact_address>.Islamic Azad University Complex, Ardabil Branch.Basij square. ARDABIL Ardabil Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
